http://osunanursery.com/imitrex.html

Coeur d'Alene Arthritis Clinic

CRAIG WIESENHUTTER M.D.

The Animated Rheumatologist

Craig Wiesenhutter's Journal Publications

The Coeur d'Alene Arthritis Clinic

Craig Wiesenhutter's Journal Publications

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM.
Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study. J Rheumatol. 2010 Apr;37(4):692-703. Epub 2009 Dec 23.

Wiesenhutter, Cw, Boice, JA, Ko, A, Sheldon, EA, Murphy, FT, Wittmer, BA, and Aversano, ML.
Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial. Mayo Clin Proc. 2005;80:470-479 © 2005

Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD.
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol. 2005 Mar;32(3):417-23.

Brunner, J, Kern, MK,Gaipl, US, Munoz, LE, Voll, RE, Kalden, JR, Wiesenhutter, CW, and Brunner, MH.
The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis. Modern Rheumatology. 2005 Feb;15(1):9-18.

Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum. 2002 Aug;46(8):2020-8.

Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY.
Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med. 2002 Jun 10;162(11):1293-300.

Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J.
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis. J Rheumatol. 2002 Feb;29(2):220-9.

Caldwell J, Gendreau RM, Furst D, Wiesenhutter C, Quagliata F, Spindler J, Bertram J.
A pilot study using a staph protein A column (Prosorba) to treat refractory rheumatoid arthritis. J Rheumatol. 1999 Aug;26(8):1657-62. Erratum in: J Rheumatol 1999 Dec;26(12):2718. Wiesenhutter CW, Irish BL, Bertram JH. Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial. J Rheumatol. 1994 May;21(5):804-12.

Wiesenhutter CW, Irish BL, Bertram JH.
Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial.
J Rheumatol. 1994 May;21(5):804-12.

Strand V, Lipsky PE, Cannon GW, Calabrese LH, Wiesenhutter C, Cohen SB, Olsen NJ, Lee ML, Lorenz TJ, Nelson B.
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group. Arthritis Rheum. 1993 May;36(5):620-30.

Wiesenhutter C, Knutson DW, Musgrave DS, Ashman RF.
IgG aggregates of different sizes stimulate or suppress Ig secretion by human lymphocytes in vitro. J Clin Immunol. 1984 Mar;4(2):124-33.

Brenner MB, Kobayashi S, Wiesenhutter CW, Huberman AK, Bales P, Yu DT.
In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA-B27 positive individuals. Arthritis Rheum. 1984 Mar;27(3):250-7.

Ashman RF, White RH, Wiesenhutter C, Cantor Y, Lasarow E, Liebling M, Talal N.
Panhypogammaglobulinemia in systemic lupus erythematosus: in vitro demonstration of multiple cellular defects. J Allergy Clin Immunol. 1982 Dec;70(6):465-73.

Wiesenhutter CW, Sharma OP.
Is sarcoidosis an autoimmune disease?: Report of four cases and review of the literature. Semin Arthritis Rheum. 1979 Nov;9(2):124-44. Review. No abstract available.

TEXTBOOK chapters

Wiesenhutter, C.W., and D.T. Yu.
Pathophysiology of Spondyloarthropathy.
Diagnosis and Treatment of Spondyloarthropathy.
UpToDate in Medicine (CD-ROM) 1992-2010).